USPTO serial 76174678
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
2333 CN Leiden, NL
2333 CN Leiden, NL
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lawrence E Abelman
LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB150 E 42ND STNEW YORK, NY 10017-5612UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents and therapeutic reagents in the nature of human monoclonal antibodies for scientific and research use in the field of human therapeutics | ACTIVE | — |
| 005 | Diagnostic and therapeutic reagents in the nature of human monoclonal antibodies for clinical medical laboratory use; medical diagnostic and therapeutic regents in the nature of human monoclonal antibodies for use in the treatment of cancer targeting, chronic inflammation, pathogenic infections, vaccination in the field of human therapeutics | ACTIVE | — |
| 042 | Laboratory research in the field of the isolation and purification of human monoclonal antibodies; laboratory research in the field of human monoclonal antibodies, namely research regarding the isolation and purification of human monoclonal antibodies; biological research and testing in the field of the isolation and purification of human monoclonal antibodies; scientific research; medical services and biochemical research regarding the production of human proteins in human cell lines and the importance of human post-translational modifications; chemical and medical research, synthesis and development of human monoclonal antibodies for others; biochemical research; laboratories and analysis for others | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 8, 2003 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 15, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 21, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 1, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 15, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 16, 2002 | PAPER RECEIVED | — | |
| Sep 13, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 13, 2002 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 15, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 23, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 4, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 30, 2001 | DOCK | ASSIGNED TO EXAMINER | — |